Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 69494

11 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 14, 2014
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Hospira Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

11 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 11

Normosol-R pH 7.4 Multiple Electrolytes Injection Type 1, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7670-09.

D-0277-2015
Recall number
D-0277-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
152,172 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 32-082-JT; Exp. 08/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 2 of 11

Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7902-09.

D-0278-2015
Recall number
D-0278-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
836,460 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 34-017-JT; Exp. 10/15 Lot # 35-100-JT; Exp. 11/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 3 of 11

5% Dextrose Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7922-09.

D-0279-2015
Recall number
D-0279-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
301,560 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 33-094-JT; Exp. 09/15 Lot # 35-028-JT; Exp. 11/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 4 of 11

5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7926-09.

D-0280-2015
Recall number
D-0280-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
823,296 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 33-095-JT; Exp. 09/15 Lot # 36-030-JT; Exp. 12/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 5 of 11

Lactated Ringer's and 5% Dextrose Injection, USP; 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7929-09.

D-0281-2015
Recall number
D-0281-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
275,448 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 34-134-JT Exp. 10/15 Lot # 34-166-JT Exp. 10/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 6 of 11

5% Dextrose and 0.9% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7941-09.

D-0282-2015
Recall number
D-0282-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
340,272 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 32-104-JT; Exp. 08/15 Lot # 34-136-JT; Exp. 10/15 Lot # 36-092-JT; Exp. 12/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 7 of 11

Lactated Ringer's Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7953-09.

D-0283-2015
Recall number
D-0283-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
6,193,416 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 32-099-JT; Exp. 08/15 Lot # 32-103-JT; Exp. 08/15 Lot # 34-070-JT; Exp. 10/15 Lot # 34-086-JT; Exp. 10/15 Lot # 34-165-JT; Exp. 10/15 Lot # 35-085-JT; Exp. 11/15 Lot # 35-115-JT; Exp. 11/15 Lot # 35-121-JT; Exp. 11/15 Lot # 36-057-JT; Exp. 12/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 8 of 11

Normosol-R Multiple Electrolytes Injection Type 1, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7967-09.

D-0284-2015
Recall number
D-0284-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
305,664 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 32-081-JT; Exp. 08/15 Lot # 34-115-JT; Exp. 10/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 9 of 11

0.9% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7983-09.

D-0285-2015
Recall number
D-0285-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
16,487,040 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 32-044-JT; Exp. 08/15 Lot # 32-072-JT; Exp. 08/15 Lot # 32-102-JT; Exp. 08/15 Lot # 33-028-JT; Exp. 09/15 Lot # 33-046-JT; Exp. 09/15 Lot # 33-049-JT; Exp. 09/15 Lot # 33-061-JT; Exp. 09/15 Lot # 33-085-JT; Exp. 09/15 Lot # 33-096-JT; Exp. 09/15 Lot # 33-101-JT; Exp. 09/15 Lot # 33-102-JT; Exp. 09/15 Lot # 34-016-JT; Exp. 10/15 Lot # 34-085-JT; Exp. 10/15 Lot # 34-122-JT; Exp. 10/15 Lot # 34-123-JT; Exp. 10/15 Lot # 35-026-JT; Exp. 11/15 Lot # 35-030-JT; Exp. 11/15 Lot # 35-067-JT; Exp. 11/15 Lot # 36-002-JT ;Exp. 12/15 Lot # 36-029-JT; Exp. 12/15 Lot # 36-049-JT; Exp. 12/15 Lot # 36-058-JT; Exp. 12/15 Lot # 36-103-JT; Exp. 12/15 Lot # 37-013-JT; Exp. 01/16

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 10 of 11

0.45% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7985-09.

D-0286-2015
Recall number
D-0286-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
784,920 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot # 33-027-JT; Exp.09/15 Lot # 33-045-JT; Exp.09/15 Lot # 33-097-JT; Exp.09/15 Lot # 35-068-JT; Exp.11/15 Lot # 36-112-JT; Exp.12/15 Lot # 37-012-JT; Exp.01/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.

drug · product 11 of 11

Sterile Water for Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7990-09.

D-0287-2015
Recall number
D-0287-2015
Initiated
October 14, 2014
Classification
Class II
Status
Terminated
Recalling firm
Hospira Inc.
Quantity
153,504 bags

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.

Code information

Lot# 36-084-JT; Exp.12/15

Distribution pattern

Nationwide, Puerto Rico, and U.S. Virgin Islands.